Chakma Justin 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Chakma Justin
Chief Business Officer
Transactions
- Award
Stock option (right to buy)
2026-01-02+240,000→ 240,000 totalExercise: $11.49Exp: 2036-01-01→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026.